Grant✓ Small businesses may apply
HEAL Initiative: Translating Addiction Epidemiology, Prevention, Treatment, and Recovery Research into Practice (R61/R33 - Clinical Trial Optional)
National Institutes of Health
- Opportunity #
- RFA-DA-27-016
- Agency
- National Institutes of Health
- ALN (CFDA)
- 93.279, 93.213, 93.273, 93.866
- Status
- posted
- Posted
- Jun 4, 2026
- Closes
- Feb 9, 2029
- Funding instrument
- Grant
- Category
- Health
- Cost sharing required
- No
Who can apply
- •County governments
- •Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
- •Independent school districts
- •For profit organizations other than small businesses
- •Private institutions of higher education
- •Small businesses
- •Native American tribal organizations (other than Federally recognized tribal governments)
- •State governments
- •Public housing authorities/Indian housing authorities
- •Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
- •City or township governments
- •Public and State controlled institutions of higher education
- •Others (see text field entitled "Additional Information on Eligibility" for clarification)
- •Native American tribal governments (Federally recognized)
- •Special district governments
Refer to Section III. Eligibility Information in the NOFO for additional information on eligibility.Foreign Organizations/International Collaborations:Non-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply.Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.Foreign components, as defined in the NIH Grants Policy Statement, are allowed.
Synopsis
The goal of this notice of funding opportunity (NOFO) is to address the opioid crisis and/or overdose events by supporting action-oriented research, accelerating the translation of addiction epidemiology, prevention, treatment services, and recovery research to practice. Proposed studies may target the individual, provider, organizational, community, or system level. This initiative prioritizes replicable and scalable approaches for accelerating the routine use of effective, evidence-based prevention, treatment and recovery interventions and services. The translation of research to practice and research relevant to chronic pain comorbid with substance use is also a priority. Research may deploy a variety of methods and approaches, including but not limited to identifying and characterizing malleable factors, developing and testing interventions and implementation strategies, deploying and testing collaborative data science approaches, and/or developing and testing approaches that integrate the collaboration of researchers and decision-makers at any levels (e.g., clinical-, health system-, public health- or policy-level).
Contact
National Institutes of Health · NIDA-26-063@nih.gov